Gaugene
Beijing
About Gaugene
Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Estimated revenue: $10K – $50K
- Total funding: $36.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2022)
- Website: gaugene.com
Industries & Categories
Biotechnology, Health Diagnostics
Canonical: https://fsome.com/organization/gaugene-11033 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.